Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Other financing activities (2022 - 2025)

Historic Other financing activities for ASP Isotopes (ASPI) over the last 4 years, with Q3 2025 value amounting to $3.7 million.

  • ASP Isotopes' Other financing activities rose 7188.83% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 6054.84%. This contributed to the annual value of $3.6 million for FY2024, which is 54748.18% up from last year.
  • ASP Isotopes' Other financing activities amounted to $3.7 million in Q3 2025, which was up 7188.83% from $1.5 million recorded in Q4 2024.
  • ASP Isotopes' 5-year Other financing activities high stood at $3.7 million for Q3 2025, and its period low was $57083.0 during Q4 2023.
  • For the 4-year period, ASP Isotopes' Other financing activities averaged around $1.2 million, with its median value being $962453.0 (2022).
  • Its Other financing activities has fluctuated over the past 5 years, first tumbled by 9528.04% in 2023, then skyrocketed by 244777.08% in 2024.
  • Quarter analysis of 4 years shows ASP Isotopes' Other financing activities stood at $1.2 million in 2022, then crashed by 95.28% to $57083.0 in 2023, then surged by 2447.77% to $1.5 million in 2024, then skyrocketed by 153.99% to $3.7 million in 2025.
  • Its Other financing activities stands at $3.7 million for Q3 2025, versus $1.5 million for Q4 2024 and $2.1 million for Q3 2024.